Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country.
作者信息
Muntañola Ana, Villacampa Guillermo, Hernández-Rivas José Ángel, Alonso Rosalía, Mirás Fátima, Osorio Santiago, Baile Mónica, Baltasar Patricia, López Jiménez Javier, Hernandez-Rodriguez Ines, Valenciano Susana, Alfayate Ana, Gimeno Eva, Bárez Abelardo, Oliveira Ana C, Riaza Rosalía, Romero Pilar, Delgado Julio, Yáñez Lucrecia, Zabalza Amaya, Torres Ana, Gómez-Roncero Mª Isabel, Crespo Marta, Córdoba Raúl, Mateos-Mazón Juan José, Pérez Sonia, Andreu Rafael, Labrador Jorge, Ruiz Mª Elena, Velasquez César Andrés, Terol Mª José, Santiago Raquel, Vidal Mª Jesús, Campoy García Fiz, Villalón Lucía, Muiña Begoña S, Soler Joan Alfons, Seri Cristina, Sánchez Mª José, Cuesta Amalia, Ramos Rafael, Sánchez-Montalvá Adrián, Ruiz-Camps Isabel, González Marcos, Abrisqueta Pau, Bosch Francesc
机构信息
Hospital Universitari Mútua Terrassa, Barcelona, Spain.
Oncology Data Science, Vall D'Hebron Institute of Oncology, Barcelona, Spain.
出版信息
Exp Hematol Oncol. 2020 Dec 18;9(1):37. doi: 10.1186/s40164-020-00195-x.
Abstract
摘要
相似文献
1
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country.
Exp Hematol Oncol. 2020 Dec 18;9(1):37. doi: 10.1186/s40164-020-00195-x.
2
Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up.
Front Oncol. 2020 Jul 3;10:1272. doi: 10.3389/fonc.2020.01272. eCollection 2020.
3
Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
Infect Dis Poverty. 2020 Jul 2;9(1):82. doi: 10.1186/s40249-020-00707-1.
4
SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
Eur J Haematol. 2021 Jan;106(1):72-81. doi: 10.1111/ejh.13519. Epub 2020 Sep 29.
5
COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges.
Pan Afr Med J. 2020 Aug 17;36:286. doi: 10.11604/pamj.2020.36.286.24361. eCollection 2020.
6
Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.
Am J Perinatol. 2020 Sep;37(11):1110-1114. doi: 10.1055/s-0040-1714060. Epub 2020 Jul 3.
7
Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.
J Matern Fetal Neonatal Med. 2020 Nov;33(22):3820-3826. doi: 10.1080/14767058.2020.1798398. Epub 2020 Jul 28.
8
COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.
Eur J Haematol. 2020 Oct;105(4):508-511. doi: 10.1111/ejh.13475. Epub 2020 Jul 10.
9
A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
Comput Biol Med. 2021 Mar;130:104219. doi: 10.1016/j.compbiomed.2021.104219. Epub 2021 Jan 16.
10
The theoretical mortality risk of an asymptomatic patient with a negative SARS-CoV-2 test developing COVID-19 following elective orthopaedic surgery.
Bone Joint J. 2020 Sep;102-B(9):1256-1260. doi: 10.1302/0301-620X.102B9.BJJ-2020-1147.R1. Epub 2020 Jul 6.
引用本文的文献
1
Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis.
Rev Assoc Med Bras (1992). 2024 Aug 16;70(8):e20240322. doi: 10.1590/1806-9282.20240322. eCollection 2024.
2
Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.
Ann Hematol. 2022 Dec;101(12):2711-2717. doi: 10.1007/s00277-022-05003-6. Epub 2022 Oct 22.
3
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.
Hematol Oncol. 2023 Feb;41(1):16-25. doi: 10.1002/hon.3084. Epub 2022 Oct 20.
4
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19.
Blood Adv. 2022 Jan 8;6(3):848-853. doi: 10.1182/bloodadvances.2021006326.
5
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
Am J Hematol. 2022 Jan 1;97(1):30-42. doi: 10.1002/ajh.26385. Epub 2021 Nov 2.
6
Management of patients with chronic lymphocytic leukemia during the SARS-CoV-2 pandemic.
Oncol Lett. 2021 Aug;22(2):636. doi: 10.3892/ol.2021.12897. Epub 2021 Jul 3.
7
The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment.
Diagnostics (Basel). 2021 May 10;11(5):853. doi: 10.3390/diagnostics11050853.
本文引用的文献
1
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
Cancer Discov. 2020 Jul 31;10(10):1465-74. doi: 10.1158/2159-8290.CD-20-0773.
2
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood. 2020 Sep 3;136(10):1134-1143. doi: 10.1182/blood.2020006965.
3
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Leukemia. 2020 Sep;34(9):2354-2363. doi: 10.1038/s41375-020-0959-x. Epub 2020 Jul 9.
4
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report.
Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.
5
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.
Sci Immunol. 2020 Jun 5;5(48). doi: 10.1126/sciimmunol.abd0110.
6
Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
Br J Haematol. 2020 Jul;190(2):e73-e76. doi: 10.1111/bjh.16863. Epub 2020 Jun 4.
7
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.
Blood. 2020 May 21;135(21):1912-1915. doi: 10.1182/blood.2020006288.
8
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
9
Perturbation of the normal immune system in patients with CLL.
Blood. 2015 Jul 30;126(5):573-81. doi: 10.1182/blood-2015-03-567388. Epub 2015 Jun 17.
Zotero 插件